EVP, Chief Legal OfficerCIK 0001798679
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Matsuda MasaruEVP, Chief Legal Officer |  ARQTArcutis Biotherapeutics, Inc.Option exercise · 10b5-1 plan | M | — 40.0K sh | Nov 4, 2026 traded Nov 4, 2026 | |
Matsuda MasaruEVP, Chief Legal Officer |
| ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan |
| SELL |
| $39K 1,219 sh |
| Nov 4, 2026 traded Nov 2, 2026 |
| 3 | Matsuda MasaruEVP, Chief Legal Officer | ARQTArcutis Biotherapeutics, Inc. Option exercise · 10b5-1 plan | M | $146K 40.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 25 | Matsuda MasaruEVP, Chief Legal Officer | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.37M 40.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 1 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $92K 3,674 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 10 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $250K 9,989 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 11 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 884 sh | May 6, 2026 traded May 4, 2026 |
| 18 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $172K 7,372 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $28K 989 sh | Nov 21, 2025 traded Nov 19, 2025 |
| 16 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 1,561 sh | Nov 21, 2025 traded Nov 19, 2025 |
| 23 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $177K 7,165 sh | Nov 5, 2025 traded Nov 3, 2025 |
| 20 | Matsuda MasaruSee Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1,092 43 sh | Nov 5, 2025 traded Nov 3, 2025 |